APA (7th ed.) Citation

Signorelli, C., Calegari, M. A., Basso, M., Anghelone, A., Lucchetti, J., Minelli, A., . . . Zoratto, F. (2023). Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study. Current Oncology, 30(6), 5456. https://doi.org/10.3390/curroncol30060413

Chicago Style (17th ed.) Citation

Signorelli, Carlo, et al. "Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and Beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study." Current Oncology 30, no. 6 (2023): 5456. https://doi.org/10.3390/curroncol30060413.

MLA (9th ed.) Citation

Signorelli, Carlo, et al. "Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and Beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study." Current Oncology, vol. 30, no. 6, 2023, p. 5456, https://doi.org/10.3390/curroncol30060413.